ESTRO Multidisciplinary Management of Breast Cancer 2017

Long Term Morbidity after ALND

35%

29.9%

30%

26.7%

23.9%

25.6%

breast conserving therapy (n=306)

25%

22.9%

mastectomy (n=90)

18.9%

20%

17.6%

14.4%

15% patients

8.9%

10%

5.6%

5%

3.3%

2.6%

0%

arm problems

no problems

fear for cancer recurrence

others

aesthetic problems

general weakness

T.Kuehn et al. Breast Cancer Res Treat 2000